Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.22854 | 49 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.21729 | 51 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.21154 | 50 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.32963 | 55 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.15588 | 50 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.23918 | 48 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.21553 | 48 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.19303 | 50 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.20112 | 51 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.24329 | 52 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.20297 | 50 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.20484 | 51 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.21579 | 50 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.26302 | 52 |